Measurement of plasma gentamicin concentrations postchemical ciliary body ablation in dogs with chronic glaucoma.

OBJECTIVE To investigate the absorption of gentamicin into the plasma after an intravitreal injection in dogs and to report the success rate of this procedure in lowering the intraocular pressure. ANIMALS Twenty-four client-owned dogs with chronic, end-stage glaucoma. PROCEDURES Dogs received a unilateral (22) or bilateral (2) intravitreal injection of 25-40 mg of gentamicin (mean ± SD dose 2.57 ± 1.65 mg/kg and range 0.61-7.50 mg/kg) and 1 mg of dexamethasone per eye. Blood samples were collected at various time points following the intravitreal injection. Plasma concentrations of gentamicin were determined by liquid chromatography and mass spectrometry. RESULTS The total plasma concentration of gentamicin ranged from 0.21 to 9.71 μg/mL (mean ± SD 2.15 ± 2.03). The mean gentamicin CMAX was 2.29 μg/mL at 2.54 h with a terminal half-life of 9.8 h. The success rate of the chemical ablation procedure was 86.4% (19/22 eyes) in dogs that had at least 1 month of follow-up. CONCLUSIONS Intravitreal injection of gentamicin in eyes with chronic glaucoma resulted in detectable plasma levels in dogs and was successful in lowering the intraocular pressure in 86.4% of the eyes after the first procedure.

[1]  R. Dubielzig,et al.  Canine ocular tumors following ciliary body ablation with intravitreal gentamicin. , 2013, Veterinary ophthalmology.

[2]  R. Dubielzig,et al.  Feline ocular tumors following ciliary body ablation with intravitreal gentamicin. , 2013, Veterinary ophthalmology.

[3]  P. Toutain,et al.  Plasma terminal half-life. , 2004, Journal of veterinary pharmacology and therapeutics.

[4]  D. Maurice,et al.  Review: practical issues in intravitreal drug delivery. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[5]  K. Abrams.  Medical and surgical management of the glaucoma patient. , 2001, Clinical techniques in small animal practice.

[6]  T. O’Brien,et al.  Evaluation of urine gamma-glutamyl transpeptidase-to-creatinine ratio as a diagnostic tool in an experimental model of aminoglycoside-induced acute renal failure in the dog. , 1996, Journal of the American Animal Hospital Association.

[7]  J. Riviere,et al.  Increased gentamicin nephrotoxicity in normal and diseased dogs administered identical serum drug concentration profiles: increased sensitivity in subclinical renal dysfunction. , 1986, The Journal of pharmacology and experimental therapeutics.

[8]  J. Baum,et al.  Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. , 1983, Investigative ophthalmology & visual science.

[9]  R. Bulger,et al.  Effect of potassium depletion on tubular morphology in gentamicin-induced acute renal failure in dogs. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[10]  R. Forster,et al.  The clearance of intravitreal gentamicin. , 1981, American journal of ophthalmology.

[11]  J. Baum,et al.  Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution. , 1981, Investigative ophthalmology & visual science.

[12]  N. Glickman,et al.  Intraocular gentamicin and glaucoma: A retrospective study of 60 dog and cat eyes (1985-1993) , 1995 .

[13]  M. Tateyama,et al.  [Aminoglycoside antibiotics]. , 1990, Nihon rinsho. Japanese journal of clinical medicine.

[14]  D. Aucoin,et al.  Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs. , 1988, Journal of the American Veterinary Medical Association.